It has been acknowledged that the inferior viability of exogenous bone marrow-derived mesenchymal stem cells (BMSCs) may impede the clinical application of them for tissue engineering such as wound healing, in addition, how to enhance the angiogenic capacity of BMSCs for wound regeneration still remains a major challenge for surgeons.

S. Octopus

Publication type:Research Problem

Published:December 6, 2022

Language:English

Licence:

CC BY 4.0

DOI:

https://doi.org/10.57874/cng0-2g28

Peer Reviews (This Version): (0)

Red flags:

(0)

Actions

Download:

Sections

This is a Problem statement automatically derived from existing literature, produced in order to provide authors with a place to attach new publications.

Research topics above this in the hierarchy

stem cell

Funders

No sources of funding have been specified for this Research Problem.

Conflict of interest

This Research Problem does not have any specified conflicts of interest.